Research V on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: A Questionnaire Survey and Result Analysis on Regulatory System of Pharmacovigilance and Risk Control in China

Yang Jianhong, Zuo Xiaochun, Zhi Huijing, Feng Hongyun, Li Hao, Zhou Lingyun, Zhan Xiaojing, Lü Xinhuan, Chen Jiangpeng, Zhang Xianglin

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (6) : 644-658.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (6) : 644-658. DOI: 10.16153/j.1002-7777.2022.06.007

Research V on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: A Questionnaire Survey and Result Analysis on Regulatory System of Pharmacovigilance and Risk Control in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(6): 644-658 https://doi.org/10.16153/j.1002-7777.2022.06.007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉